Please join us for this webinar by Raul Condemarin, MD.

Despite having multiple new medications every year for the treatment of depression, schizophrenia, and mood disorders the outcome has not improved as expected. We have moved from a psychodynamic-oriented framework to a biological one but still not having the desired outcome. Medication non-adherence and treatment resistance remain big issues daily. It is well known that people with a trauma history have more tendency to be nonadherence to treatment. Taking into consideration the psychodynamic and psychosocial aspects at the time of prescribing can play a significant factor to improve the treatment outcome.